Curis Prices $5.6M Offering at Steep Discount to 52-Week Low
CRIS is trading near its 52-week low of $1.63 (10% below the low) on elevated volume (5.5× avg).
Summary
Curis priced a $5.6 million public offering, a modest raise relative to the $30 million S-1 filed August 10. The company trades near its 52-week low of $1.63, and the offering is highly dilutive given its $3.25 million market cap. This follows a 1-for-20 reverse split in July to regain Nasdaq compliance and a going-concern warning in the last 10-Q. The raise provides short-term runway but underscores the company's cash burn and lack of revenue.
At the time of this announcement, CRIS was trading at $1.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $1.63 to $39.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.